Wilson Sonsini Goodrich & Rosati has advised SR One.Avenzo Therapeutics, Inc., a clinical-stage biotechnology company focused on developing next-generation oncology therapies, has closed a $60 million…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
